U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 00:28:33 GMT 2023
Edited
by admin
on Sat Dec 16 00:28:33 GMT 2023
Protein Sub Type
Sequence Type COMPLETE
Record UNII
23CA79S88F
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TASONERMIN
EMA EPAR   INN   MART.   WHO-DD  
INN  
Official Name English
TUMOR NECROSIS FACTOR .ALPHA. (SOLUBLE, HUMAN, RECOMBINANT, E. COLI)
Common Name English
TUMOR NECROSIS FACTOR, SOLUBLE FORM, NONGLYCOSYLATED
Common Name English
TUMOR NECROSIS FACTOR, SOLUBLE FORM (RECOMBINANT E. COLI)
Common Name English
FK-516
Code English
Tasonermin [WHO-DD]
Common Name English
BEROMUN
Brand Name English
RECOMBINANT HUMAN TNF-.ALPHA. (NON-GLYCOSYLATED)
Common Name English
TASONERMIN [MART.]
Common Name English
FK 516
Code English
tasonermin [INN]
Common Name English
TASONERMIN [EMA EPAR]
Common Name English
1-157-TUMOR NECROSIS FACTOR ALFA-1A (HUMAN), NON-GLYCOSYLATED
Common Name English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS BEROMUN (AUTHORIZED: SARCOMA)
Created by admin on Sat Dec 16 00:28:33 GMT 2023 , Edited by admin on Sat Dec 16 00:28:33 GMT 2023
NCI_THESAURUS C913
Created by admin on Sat Dec 16 00:28:33 GMT 2023 , Edited by admin on Sat Dec 16 00:28:33 GMT 2023
WHO-VATC QL03AX11
Created by admin on Sat Dec 16 00:28:33 GMT 2023 , Edited by admin on Sat Dec 16 00:28:33 GMT 2023
WHO-ATC L03AX11
Created by admin on Sat Dec 16 00:28:33 GMT 2023 , Edited by admin on Sat Dec 16 00:28:33 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID50273964
Created by admin on Sat Dec 16 00:28:33 GMT 2023 , Edited by admin on Sat Dec 16 00:28:33 GMT 2023
PRIMARY
EVMPD
SUB12605MIG
Created by admin on Sat Dec 16 00:28:33 GMT 2023 , Edited by admin on Sat Dec 16 00:28:33 GMT 2023
PRIMARY
INN
7581
Created by admin on Sat Dec 16 00:28:33 GMT 2023 , Edited by admin on Sat Dec 16 00:28:33 GMT 2023
PRIMARY
DRUG BANK
DB11626
Created by admin on Sat Dec 16 00:28:33 GMT 2023 , Edited by admin on Sat Dec 16 00:28:33 GMT 2023
PRIMARY
RXCUI
283746
Created by admin on Sat Dec 16 00:28:33 GMT 2023 , Edited by admin on Sat Dec 16 00:28:33 GMT 2023
PRIMARY RxNorm
CAS
94948-59-1
Created by admin on Sat Dec 16 00:28:33 GMT 2023 , Edited by admin on Sat Dec 16 00:28:33 GMT 2023
PRIMARY
FDA UNII
23CA79S88F
Created by admin on Sat Dec 16 00:28:33 GMT 2023 , Edited by admin on Sat Dec 16 00:28:33 GMT 2023
PRIMARY
NCI_THESAURUS
C134821
Created by admin on Sat Dec 16 00:28:33 GMT 2023 , Edited by admin on Sat Dec 16 00:28:33 GMT 2023
PRIMARY
SMS_ID
100000089313
Created by admin on Sat Dec 16 00:28:33 GMT 2023 , Edited by admin on Sat Dec 16 00:28:33 GMT 2023
PRIMARY
ChEMBL
CHEMBL2107891
Created by admin on Sat Dec 16 00:28:33 GMT 2023 , Edited by admin on Sat Dec 16 00:28:33 GMT 2023
PRIMARY
DRUG CENTRAL
5212
Created by admin on Sat Dec 16 00:28:33 GMT 2023 , Edited by admin on Sat Dec 16 00:28:33 GMT 2023
PRIMARY
From To
2_69 2_101
1_69 1_101
3_69 3_101
Related Record Type Details
TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1A
TARGET -> AGONIST
Related Record Type Details
TASONERMIN
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:CALCULATED CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966